ZBTB11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.365200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.637000E-01
Normal-vs-Stage2
5.378200E-01
Normal-vs-Stage3
3.183600E-01
Normal-vs-Stage4
7.799600E-01
Stage1-vs-Stage2
6.433600E-01
Stage1-vs-Stage3
6.616100E-02
Stage1-vs-Stage4
9.305900E-02
Stage2-vs-Stage3
1.321240E-01
Stage2-vs-Stage4
1.080090E-02
Stage3-vs-Stage4
9.503400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.334400E-01
Normal-vs-AfricanAmerican
6.434400E-01
Normal-vs-Asian
1.188790E-01
Caucasian-vs-AfricanAmerican
3.287800E-01
Caucasian-vs-Asian
1.769050E-01
AfricanAmerican-vs-Asian
1.409370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.401400E-01
Normal-vs-Female
5.377600E-01
Male-vs-Female
9.665000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.970200E-01
Normal-vs-Age(41-60Yrs)
6.794000E-01
Normal-vs-Age(61-80Yrs)
4.920400E-01
Normal-vs-Age(81-100Yrs)
4.163400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.812400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.813800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.743800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.176500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.406100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.175200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.696400E-01
Normal-vs-Daily Drinker
3.939800E-01
Normal-vs-Weekly Drinker
4.784400E-01
Normal-vs-Occasional Drinker
5.138200E-01
Normal-vs-Social Drinker
3.407000E-01
Non Drinker-vs-Daily Drinker
3.050000E-01
Non Drinker-vs-Weekly Drinker
9.665000E-01
Non Drinker-vs-Occasional Drinker
1.369370E-01
Non Drinker-vs-Social Drinker
3.820000E-01
Daily Drinker-vs-Weekly Drinker
3.952400E-01
Daily Drinker-vs-Occasional Drinker
2.794000E-02
Daily Drinker-vs-Social Drinker
1.263010E-01
Weekly Drinker-vs-Occasional Drinker
2.214200E-01
Weekly Drinker-vs-Social Drinker
5.201000E-01
Occasional Drinker-vs-Social Drinker
5.662600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.096560E-01
Normal-vs-Grade 2
6.857200E-03
Normal-vs-Grade 3
1.651520E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.206000E-01
Grade 1-vs-Grade 3
1.827010E-01
Grade 1-vs-Grade 4
1.096560E-01
Grade 2-vs-Grade 3
7.930000E-01
Grade 2-vs-Grade 4
6.857200E-03
Grade 3-vs-Grade 4
1.651520E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.700400E-01
Normal-vs-NonDiabetic
5.026200E-01
Diabetic-vs-NonDiabetic
5.908200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.489000E-01
Normal-vs-NoPancreatitis
5.088200E-01
Pancreatitis-vs-NoPancreatitis
5.297400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.234400E-01
Normal-vs-N1
5.432800E-01
N0-vs-N1
9.942400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.818400E-01
Normal-vs-TP53-NonMutant
5.949200E-01
TP53-Mutant-vs-TP53-NonMutant
3.692000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
